Detecting biomarkers of early Atrial Transformation in AF
This 10-year large scale, 3000 patient study is designed to detect biomarkers of early atrial transformation in atrial fibrillation.
The study uses Vivalink’s multi-vital wearable ECG monitor to capture the ECG rhythm of subjects one week per month for extended periods.
Customized patient app
Data integration options
Flexible data formats
Data support services
Continuous cardiac sensors directly shipped to sites
Ready to go, pre-provisioned devices
Training
Technical support
The capabilities of the Vivalink ECG sensor will enable us to capture a larger continuous dataset in order to help achieve our goals."
-Jeffrey Olgin, MD, UCSF Chief of Cardiology
51 E. Campbell Avenue, Suite 160
Campbell, California 95008
Sales: info@vivalink.com
Support: support@vivalink.com